Investigating the association of proton pump inhibitors with chronic kidney disease and its impact on clinical practice and future research: a review

BACKGROUND: Proton pump inhibitors (PPIs) are used worldwide for the treatment of gastroesophageal reflux disease (GERD) and peptic ulcer disease (PUD). Although considered to be widely safe, PPIs have been associated with the potential risk of adverse effects such as infections including pneumonia...

Descripción completa

Detalles Bibliográficos
Autor principal: Cheema, Ejaz
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6440100/
https://www.ncbi.nlm.nih.gov/pubmed/30976431
http://dx.doi.org/10.1186/s40545-019-0167-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6440100/
https://www.ncbi.nlm.nih.gov/pubmed/30976431
http://dx.doi.org/10.1186/s40545-019-0167-0

Ejemplares similares